These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22066734)

  • 1. Relationship between NF-κB1 and NF-κBIA genetic polymorphisms and Crimean-Congo hemorrhagic fever.
    Arslan S; Engin A
    Scand J Infect Dis; 2012 Feb; 44(2):138-43. PubMed ID: 22066734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 7 Gln11Leu, c.4-151A/G, and +1817G/T polymorphisms in Crimean Congo hemorrhagic fever.
    Arslan S; Engin A; Özbilüm N; Bakır M
    J Med Virol; 2015 Jul; 87(7):1090-5. PubMed ID: 25879168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of TLR10 (2322A/G, 720A/C, and 992T/A) polymorphisms on the pathogenesis of Crimean Congo hemorrhagic fever disease.
    Kızıldağ S; Arslan S; Özbilüm N; Engin A; Bakır M
    J Med Virol; 2018 Jan; 90(1):19-25. PubMed ID: 28843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever.
    Karakus N; Yigit S; Duygu F; Barut S; Rustemoglu A; Basol N
    Gene; 2019 Mar; 687():188-192. PubMed ID: 30465883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between IFNA1, IFNA5, IFNA10, and IFNA17 gene polymorphisms and Crimean-Congo hemorrhagic fever prognosis in a Turkish population range.
    Elaldi N; Yilmaz M; Bagci B; Yelkovan I; Bagci G; Gozel MG; Engin A; Bakir M; Dokmetas I
    J Med Virol; 2016 Jul; 88(7):1159-67. PubMed ID: 26694082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever.
    Engin A; Arslan S; Kizildag S; Oztürk H; Elaldi N; Dökmetas I; Bakir M
    Microbes Infect; 2010 Nov; 12(12-13):1071-8. PubMed ID: 20674764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of MCP-1 promotor polymorphism with disease severity of Crimean-Congo hemorrhagic fever.
    Bagci B; Bagci G; Buyuktuna SA; Elaldi N
    J Med Virol; 2020 Dec; 92(12):2976-2982. PubMed ID: 32219866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any relationship between Toll-like receptor 3 c.1377C/T and -7C/A polymorphisms and susceptibility to Crimean Congo hemorrhagic fever?
    Engin A; Arslan S; Özbilüm N; Bakir M
    J Med Virol; 2016 Oct; 88(10):1690-6. PubMed ID: 26959380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumour necrosis factor-alpha and interleukin-6 promoter polymorphisms on course of Crimean-Congo hemorrhagic fever in Turkish patients.
    Yilmaz M; Elaldi N; Bagci B; Sari I; Gümüs E; Yelkovan I
    J Vector Borne Dis; 2015 Mar; 52(1):30-5. PubMed ID: 25815864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene-tetrahydrofolate reductase gene C677T and A1298C polymorphisms as a risk factor for Crimean-Congo hemorrhagic fever.
    Karakus N; Duygu F; Rustemoglu A; Yigit S
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(9):878-890. PubMed ID: 35666819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever.
    Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
    Scand J Infect Dis; 2010 May; 42(5):385-8. PubMed ID: 20095935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to fatalities and clinical progression of Crimean-Congo hemorrhagic fever patients and the effects of IL 28-B gene polymorphism.
    Aytekin FY; Barut HŞ; Rüstemoğlu A; Atay A; Günal Ö; Duygu F
    Arch Virol; 2019 Feb; 164(2):547-557. PubMed ID: 30478788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the human leukocyte antigen system and Crimean-Congo hemorrhagic fever in the Turkish population.
    Akıncı E; Bodur H; Muşabak U; Sağkan RI
    Int J Infect Dis; 2013 Nov; 17(11):e1038-41. PubMed ID: 23911239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of eNOS gene 4a/4b VNTR and T786C polymorphism with Crimean-Congo hemorrhagic fever.
    Say Coskun US; Yigit S; Ozmen ZC; Deveci K; Tekcan A; Barut HS; Dagcioglu Y
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(7):507-515. PubMed ID: 36584289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crimean-Congo hemorrhagic fever.
    Whitehouse CA
    Antiviral Res; 2004 Dec; 64(3):145-60. PubMed ID: 15550268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis.
    Burt FJ; Swanepoel R; Shieh WJ; Smith JF; Leman PA; Greer PW; Coffield LM; Rollin PE; Ksiazek TG; Peters CJ; Zaki SR
    Arch Pathol Lab Med; 1997 Aug; 121(8):839-46. PubMed ID: 9278612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible role of CCR5Δ32 mutation in Crimean-Congo hemorrhagic fever infection.
    Rustemoglu A; Ekinci D; Nursal AF; Barut S; Duygu F; Günal Ö
    J Med Virol; 2017 Oct; 89(10):1714-1719. PubMed ID: 28547880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR.
    Kubar A; Haciomeroglu M; Ozkul A; Bagriacik U; Akinci E; Sener K; Bodur H
    Jpn J Infect Dis; 2011; 64(5):439-43. PubMed ID: 21937830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical investigation of the transient evoked otoacoustic emission test in Crimean-Congo hemorrhagic fever.
    Engin A; Yildirim A; Kunt T; Bakir M; Dokmetas I; Ozdemir L
    Int J Infect Dis; 2008 Mar; 12(2):162-5. PubMed ID: 17714968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
    Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
    J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.